SSSG.Y Stock Overview
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Sartorius Aktiengesellschaft Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €53.77 |
| 52 Week High | €55.28 |
| 52 Week Low | €53.77 |
| Beta | 0.84 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -36.10% |
| 5 Year Change | n/a |
| Change since IPO | -35.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| SSSG.Y | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 0% | 1.4% | 3.3% |
| 1Y | n/a | 4.9% | 25.8% |
Return vs Industry: Insufficient data to determine how SSSG.Y performed against the US Life Sciences industry.
Return vs Market: Insufficient data to determine how SSSG.Y performed against the US Market.
Price Volatility
| SSSG.Y volatility | |
|---|---|
| SSSG.Y Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 6.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SSSG.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SSSG.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1870 | 14,614 | Joachim Kreuzburg | www.sartorius.com |
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products.
Sartorius Aktiengesellschaft Fundamentals Summary
| SSSG.Y fundamental statistics | |
|---|---|
| Market cap | US$23.42b |
| Earnings (TTM) | US$222.70m |
| Revenue (TTM) | US$3.69b |
118.4x
P/E Ratio7.2x
P/S RatioIs SSSG.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SSSG.Y income statement (TTM) | |
|---|---|
| Revenue | €3.40b |
| Cost of Revenue | €1.83b |
| Gross Profit | €1.57b |
| Other Expenses | €1.36b |
| Earnings | €205.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 18, 2024
| Earnings per share (EPS) | 2.97 |
| Gross Margin | 46.15% |
| Net Profit Margin | 6.04% |
| Debt/Equity Ratio | 187.3% |
How did SSSG.Y perform over the long term?
See historical performance and comparison